AC
MSACW

Ayrton Capital’s Medicus Sciences Acquisition Corp. Warrant MSACW Stock Holding History

Ayrton Capital’s Portfolio MSACW Stock Details MSACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,111
Closed -$1K – 101
2022
Q4 		$1K Hold
11,111
– – ﹤0.01% 90
2022
Q3 		$2K Hold
11,111
– – ﹤0.01% 115
2022
Q2 		$3K Hold
11,111
– – ﹤0.01% 116
2022
Q1 		$5K Hold
11,111
– – 0.01% 122
2021
Q4 		$8K Buy
+11,111
New +$8.17K 0.01% 118

Ayrton Capital's MSACW Position: Q1 2023 in Review

Ayrton Capital sold out of Medicus Sciences Acquisition Corp. Warrant (MSACW) in Q1 2023, closing a stake of 11,111 shares — an estimated $1K sold.

Ayrton Capital first reported a position in MSACW in Q4 2021 and held it in 5 quarters. The position peaked at $8K in Q4 2021. 0 funds tracked by Wall St. Rank hold MSACW as of Q1 2023.

  • Ayrton Capital reported no remaining Medicus Sciences Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
  • Ayrton Capital sold 11,111 Medicus Sciences Acquisition Corp. Warrant shares in Q1 2023, an estimated $1K.
  • Ayrton Capital first reported a position in Medicus Sciences Acquisition Corp. Warrant in Q4 2021 and held it in 5 quarters.
  • Ayrton Capital's Medicus Sciences Acquisition Corp. Warrant position peaked at $8K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Warrant as of Q1 2023.

Based on Ayrton Capital's 13F filing for Q1 2023, filed 12 May 2023.